The Safety and Efficacy of a Proprietary Bioactive Fatty Acids Extract From Saw Palmetto (Serenoa repens) for Promoting Hair Growth and Reducing Hair Loss in Adults With Self-Perceived Thinning Hair: 90-Day Results

J Cosmet Dermatol. 2025 Dec;24(12):e70585. doi: 10.1111/jocd.70585.

Abstract

Background: Hair loss is a global concern for both men and women.

Aims: This study assessed the efficacy and safety of a proprietary extract of bioactive fatty acids from saw palmetto for treating self-perceived thinning hair in healthy adult male and female subjects.

Methods: In this 6-month, randomized, double-blind, placebo-controlled study, subjects were randomized to receive active treatment (n = 40) or placebo (n = 20). Half of the enrolled subjects were female. Subjects took one oral dose of their assigned treatment daily. Assessments were performed at baseline, Day 56 and Day 90. Preliminary 90-day results are presented here.

Patients/methods: The active group showed significant improvement in terminal hair count from baseline in anterior (p < 0.0007) and posterior (p < 0.0005) areas. Compared to placebo, the improvement was also significant in the anterior (p < 0.05) and posterior (p < 0.03) areas. Anterior vellus hair count improved significantly versus baseline (p < 0.0005) and placebo (p < 0.01). Posterior vellus hair count showed significant within-group growth (p < 0.05). Total hair count was significantly greater than baseline for anterior (p < 0.001) and posterior (p < 0.0005) and significantly greater for anterior (p < 0.005) and posterior (p < 0.05) compared to placebo. Total terminal hair counts improved 7-fold, and total hair count improved 12-fold compared to placebo. A significant reduction in hair shedding was observed in the active group versus baseline (p < 0.05). No meaningful improvements were observed in the placebo group, and no adverse events were reported.

Conclusion: These preliminary results indicate the daily administration of a proprietary saw palmetto (Serenoa repens) extract safely and effectively promotes hair growth in men and women with self-perceived thinning hair.

Trial registration: Clinicaltrials.gov identifier: NCT06920758.

Keywords: Serenoa repens; alopecia; clinical trial; hair shedding; male and female pattern hair loss; saw palmetto; thinning hair.

Publication types

  • Randomized Controlled Trial

MeSH terms

  • Adult
  • Alopecia* / drug therapy
  • Double-Blind Method
  • Fatty Acids* / administration & dosage
  • Fatty Acids* / adverse effects
  • Fatty Acids* / therapeutic use
  • Female
  • Hair* / drug effects
  • Hair* / growth & development
  • Humans
  • Male
  • Middle Aged
  • Phytotherapy
  • Plant Extracts* / administration & dosage
  • Plant Extracts* / adverse effects
  • Plant Extracts* / therapeutic use
  • Serenoa* / chemistry
  • Treatment Outcome
  • Young Adult

Substances

  • Plant Extracts
  • Fatty Acids
  • saw palmetto extract

Associated data

  • ClinicalTrials.gov/NCT06920758